Figure 5.
Altered expression of SNHG5 affects the chemo-sensitivity of K562/K562-R cells. A and B: The cell viability and IC50 values of imatinib in K562 and K562-R cells received imatinib treatment. C and D: The cell viability and IC50 values of imatinib in pcDNA3.1 or pcDNA3.1-SNHG5 transfected K562 cells received imatinib treatment. E and F: The cell viability and IC50 values of imatinib in siRNA control or SNHG5 siRNA transfected K562-R cells received imatinib treatment. Significant differences between groups were shown as *P<0.05, **P<0.01, ***P<0.001.